# Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

> **NCT05203315** · PHASE3 · COMPLETED · sponsor: **Austin Institute for Clinical Research** · enrollment: 21 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Duobrii 0.01 % / 0.045 % Topical Lotion
- **DRUG:** CeraVe, Topical Cream

## Key facts

- **NCT ID:** NCT05203315
- **Lead sponsor:** Austin Institute for Clinical Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-13
- **Primary completion:** 2023-10-04
- **Final completion:** 2023-10-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203315, "Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05203315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*